60.2
Senti Biosciences Holdings, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
103
FY23:
71.2
FY24:
59.0
FY25:
23.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
36.5
FY22:
78.2
FY23:
48.3
FY24:
38.9
FY25:
27.9
Total assets
Change from FY21 to FY25
millions USD
FY21:
96.7
FY22:
181
FY23:
119
FY24:
97.8
FY25:
51.2
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
14.5
FY22:
18.1
FY23:
12.7
FY24:
13.1
FY25:
14.0
(negative)
Change from FY21 to FY25
millions USD
FY21:
21.8
FY22:
35.5
FY23:
39.9
FY24:
33.9
FY25:
31.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−111
FY22:
127
FY23:
66.9
FY24:
25.6
FY25:
5.59
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
181
FY23:
119
FY24:
–
FY25:
51.2
All amounts in millions USD